Sterling Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Sterling Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,930	Closed	-$27.9K	–	3327
2026 Q1	$27.9K	Sell	1,930 -16	-0.8%	-$229	﹤0.01%	1868
2025 Q4	$27.7K	Buy	1,946 +1,271	+188%	+$12.5K	﹤0.01%	2060
2025 Q3	$5.32K	Buy	675 +2	+0.3%	+$14	﹤0.01%	2754
2025 Q2	$3.86K	Buy	673 +362	+116%	+$2.34K	﹤0.01%	2650
2025 Q1	$2.54K	Buy	311 +13	+4%	+$120	﹤0.01%	2498
2024 Q4	$2.81K	Hold	298	–	–	﹤0.01%	2671
2024 Q3	$3.18K	Buy	+298	New	+$3.25K	﹤0.01%	1967
2017 Q4	–	Sell	-14,455	Closed	-$218K	–	909
2017 Q3	$218K	Buy	+14,455	New	+$191K	﹤0.01%	874
2015 Q3	–	Sell	-13,664	Closed	-$193K	–	983
2015 Q2	$193K	Buy	+13,664	New	+$164K	﹤0.01%	854

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Sterling Capital Management's FOLD Position: Q2 2026 in Review

Sterling Capital Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 1,930 shares — an estimated $27.9K sold.

Sterling Capital Management first reported a position in FOLD in Q2 2015 and held it in 9 quarters. The position peaked at $218K in Q3 2017. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Sterling Capital Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Sterling Capital Management sold 1,930 Amicus Therapeutics shares in Q2 2026, an estimated $27.9K.
Sterling Capital Management first reported a position in Amicus Therapeutics in Q2 2015 and held it in 9 quarters.
Sterling Capital Management's Amicus Therapeutics position peaked at $218K in Q3 2017.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.